Condition

BRCA-Mutated

ClinicalTrials.gov condition label

Clinical trials1

Recruiting0

Common interventions1

Lead sponsors shown1

Clinical trials

1 shown

Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate CancerNCT07591467 · 2026-09-01

NOT_YET_RECRUITING

Common interventions

ExperimentalDRUG1

Leading sponsors

Gustave Roussy, Cancer Campus, Grand Paris1

Trial status mix

NOT_YET_RECRUITING1

Phase mix

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.